C-Ray Therapeutics, a radiopharmaceutical Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has achieved Full Accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). The accreditation is awarded to organizations that demonstrate compliance
AtomVie Global Radiopharma, a radiopharmaceutical contract development and manufacturing organization (CDMO), announced that it has supplied the first patient dose in Radiopharm Theranostics’ First-in-Human Phase 1/2a clinical study of 177Lu-BetaBart (RV-01). AtomVie provided GMP manufacturing and distribution services for the
Avid Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), has announced the grand opening of its new Early Phase Center of Excellence in Costa Mesa, California. The 78,000 square foot facility is purpose-built to support early clinical programs
NorthX Biologics and Demeetra have announced a strategic collaboration to provide an integrated solution spanning advanced cell line development (CLD), master cell banking (MCB), and GMP manufacturing services. The offering combines a GS (−/−) CHO cell line platform with full
Flamma Group, a contract development and manufacturing organization (CDMO) focused on new chemical entities and late-stage intermediates, announced that its Flamma USA site in Malvern, Pennsylvania has passed its first U.S. Food and Drug Administration (FDA) inspection. The four-day pre-approval
AbbVie has announced a $380 million investment to construct two new active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago, Illinois campus. The facilities will integrate advanced manufacturing technologies and artificial intelligence to support production of next-generation neuroscience and
Akums Drugs & Pharmaceuticals Ltd., an India-based contract development and manufacturing organization (CDMO), has secured EU GMP certification for two of its manufacturing facilities located in India. The certification includes renewal for its oral solid dosage facility and fresh approval
Bora Pharmaceuticals Co., Ltd. has signed a strategic agreement with GSK to renew a five-year manufacturing partnership. Bora purchased GSK’s Mississauga facility in 2020. The renewed agreement expands the collaboration and provides GSK access to multiple sites within Bora’s network,
The pharmaceutical industry is witnessing unprecedented demand for sterile injectable products, particularly those with complex formulations and specialized delivery requirements. As molecules become more sophisticated and viscosities climb, the need for CDMOs with deep technical expertise and flexible capabilities has
Seda has announced the establishment of a new Swedish presence at Medicon Village in Lund, one of Scandinavia’s life science hubs. The move marks an expansion of the company’s activities in the Nordic region. Medicon Village hosts more than 2,800
